Ph- Asthma Flashcards
What is the pathogenesis of asthma due to?
What are the 3 major cell types that infiltrate the lung of asthmatic patients?
It is due to persistent low-level inflammation of the airways caused by release of cytokines and inflammatory mediators by resident mast cells and infiltrating cells.
The airways are filled with:
- eosinophils
- neutrophils
- lymphocytes
Describe the acute response of asthma.
Allergens (via IgE) or non-specific stimuli (directly) activate sensitized mast cells and cause degranulation.
- Preformed mediators (histamine, heparin, proteases) are released
- LTs, PGs, and PAF are synthesized and released
Immediate inflammatory response occurs with:
- bronchoconstriction
- vascular congestion
- edema
Describe the chronic response of asthma.
Chemotactic factors released by mast cells and macrophages in the acute response attract other inflammatory cells from circulation into the airway epithelium.
Eosinophils, basophils and lymphocytes release additional bronchoconstrictor substances 6-10 hours after the acute attack,
What cytokines are released by T lymphocytes in asthma?
- IL3- mast cell survival
- IL4 and IL 13 (b cell switch to IgE and express adhesion molecules)
- IL5 - eosinophil differentiation and enhancement
What are the 3 main areas drug therapy for asthma target?
- bronchodilators - to relax airway smooth muscle
- reducing release of inflammatory mediators
- reducing activity of inflammatory mediators
(2 and 3 are achieved via anti-inflammatory drugs)
Why are asthma drugs administered via aerosol delivery?
Produces high local concentration at the site of action (lungs) with minimal involvement of systemic circulation (minimizing side effects).
Under the best conditions, how much of inhaled drugs make it to the lungs?
What does this imply for drug design?
10%. The other 90% is swallowed so you want to design drugs that are:
- poorly absorbed by the GI
- inactivated by first pass hepatic metabolism
What are the 2 places b2 adrenergic agonists exert their effects?
What do they do?
What type of asthma are they able to treat?
- airway smooth muscle- relaxation
- inflammatory cells- inhibit mediator release
B2 agonists are used for acute/intermittent asthma. They are ineffective at reducing airway hypersensitivity in chronic asthma
What is the major short-acting B2 agonist?
What is the onset of action? When is max effect achieved? When does it stop working?
Albuterol is used to treat acute bronchospasms. It is inhaled (but oral forms are available too)
Onset of action: 1-5 minutes
Max effect: 30 minutes
Duration of action: 2-6 hours
How does albuterol/salmeterol inhibit mediator release from mast cells?
Mast cells have a high resting potential and need to hyperpolarize to release granules.
B2 agonists close K+ channels and inhibit the release of the granules
What is the molecular mechanism by which b2 agonists work? What type of receptor do they bind? What are the intracellular effects?
B2 agonists bind Gs which increases adenyl cyclase–> increased cAMP–> PKA
PKA inhibits myosin light chain kinase which relaxes bronchial smooth muscle
PKA closes K+ channels, not allowing mast cells to hyperpolarize to degranulate
What is the role of PDE4?
It inactivates cAMP so there is no PKA to inhibit myosin light chain or inhibit mediator release
What is the long acting B2 agonist?
What form of asthma is it used to treat?
What is the onset of action? How long do effects last?
Salmeterol sticks to the bilayer with a hydrophobic tail and thus are slow to diffuse away from the receptor.
Moderate persistent/severe asthma (with inhaled glucocorticoids)
Onset of action: 2-4 hours
Duration : over 12 hours
What is salmeterol contraindicated for? Why?
It is contraindicated for monotherapy of asthma because it helps bronchodilate but has little effect on inflammation.
It should be used with a steroid (inhaled glucocorticoid)
What type of asthma are glucocorticoids used to treat?
What patients are inhaled glucocorticoids recommended for?
They are anti-inflammatory and are used to treat chronic asthma (moderate and severe).
They are recommended for any patient who requires a short acting B2 (albuterol) more than once a day.